EAM
Exome Asset Management Portfolio holdings
AUM
$110M
This Quarter Return
+11.92%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$148M
AUM Growth
+$148M
(+32%)
Cap. Flow
+$29.1M
Cap. Flow
% of AUM
19.64%
Top 10 Holdings %
Top 10 Hldgs %
35.62%
Holding
82
New
30
Increased
14
Reduced
8
Closed
23
Top Buys
| 1 |
Structure Therapeutics
GPCR
|
$5.27M |
| 2 |
Align Technology
ALGN
|
$4.76M |
| 3 |
Gilead Sciences
GILD
|
$4.19M |
| 4 |
Geron
GERN
|
$4.11M |
| 5 |
BioNTech
BNTX
|
$4.1M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$5.2M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$4.02M |
| 3 |
Corbus Pharmaceuticals
CRBP
|
$3.84M |
| 4 |
Travere Therapeutics
TVTX
|
$3.64M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$3.03M |
Sector Composition
| 1 | Healthcare | 98.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Sagimet Biosciences
SGMT
$239M
| – | – |
-50,700
| Closed | -$173K |
|
|
77
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-32,900
| Closed | -$5.2M |
|
|
78
Travere Therapeutics
TVTX
$1.75B
| – | – |
-443,379
| Closed | -$3.64M |
|
79
Wave Life Sciences
WVE
$1.27B
| – | – |
-488,135
| Closed | -$2.44M |
|
80
Zai Lab
ZLAB
$3.48B
| – | – |
-86,700
| Closed | -$1.5M |
|
81
Q32 Bio
QTTB
$20.9M
| – | – |
-43,865
| Closed | -$787K |
|